The Role of the Public Health Community in Detecting and Responding to Domestic Terrorism Involving Infectious Agents

James W. LeDuc; Stephen M. Ostroff; Joseph E. McDade; Scott Lillibridge; James M. Hughes

doi:10.1128/9781555818418.ch14

Chapter 14 : The Role of the Public Health Community in Detecting and Responding to Domestic Terrorism Involving Infectious Agents

Authors: James W. LeDuc¹, Stephen M. Ostroff¹, Joseph E. McDade¹, Scott Lillibridge¹, James M. Hughes¹

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Mailstop C· 12, Atlanta, GA 30333

Content Type: Monograph

Publication Year: 1999

Category: Clinical Microbiology

Book DOI: 10.1128/9781555818418

Chapter DOI: 10.1128/9781555818418.ch14

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

The Role of the Public Health Community in Detecting and Responding to Domestic Terrorism Involving Infectious Agents, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555818418/9781555811686_Chap14-1.gif /docserver/preview/fulltext/10.1128/9781555818418/9781555811686_Chap14-2.gif

Abstract:

The recognition of and response to actual terrorist use of an infectious agent are complicated. In contrast to chemical agents or explosive devices, whose destructive impacts are immediately recognizable, covert delivery of biological agents in the absence of notification of intent would cause disease only after an incubation period during which exposed persons could be widely dispersed. Immunohistochemical staining of autopsy tissues confirmed the existence of a previously unrecognized hantavirus approximately 1 month after the initial recognition of cases of the syndrome, but several months elapsed before the virus was finally isolated in cell culture. This experience highlights the critical importance of highly trained field and laboratory personnel, appropriate biocontainment facilities, and the laboratory reagents and sophisticated molecular techniques, all of which must be available for the detection of candidate agents that terrorists might use. The potential for bioterrorism emphasizes the urgency of strengthening the public health capacity to detect and respond to emerging infectious diseases, particularly the need to forge and strengthen partnerships between the public health and emergency response sectors. Centers for Disease Control and Prevention (CDC) maintains expertise in the detection of virtually all infectious agents pathogenic for humans and is able to use modem molecular techniques, traditional procedures for organism cultivation. Whether epidemics are the result of terrorism or natural factors, CDC and the public health community remain at the forefront of the global epidemic response.

Citation: LeDuc J, Ostroff S, McDade J, Lillibridge S, Hughes J. 1999. The Role of the Public Health Community in Detecting and Responding to Domestic Terrorism Involving Infectious Agents, p 219-230. In Scheld W, Craig W, Hughes J (ed), Emerging Infections 3. ASM Press, Washington, DC. doi: 10.1128/9781555818418.ch14

Highlighted Text: Show | Hide

Full text loading...

Figures

The Role of the Public Health Community in Detecting and Responding to Domestic Terrorism Involving Infectious Agents

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818418.chap14-1,webId=/content/author/10.1128/9781555818418.chap14-1,properties={foaf_givenname=James W., foaf_name=James W. LeDuc, foaf_surname=LeDuc, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818418.chap14-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818418.chap14-2,webId=/content/author/10.1128/9781555818418.chap14-2,properties={foaf_givenname=Stephen M., foaf_name=Stephen M. Ostroff, foaf_surname=Ostroff, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818418.chap14-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818418.chap14-3,webId=/content/author/10.1128/9781555818418.chap14-3,properties={foaf_givenname=Joseph E., foaf_name=Joseph E. McDade, foaf_surname=McDade, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818418.chap14-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818418.chap14-4,webId=/content/author/10.1128/9781555818418.chap14-4,properties={foaf_givenname=Scott, foaf_name=Scott Lillibridge, foaf_surname=Lillibridge, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818418.chap14-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818418.chap14-5,webId=/content/author/10.1128/9781555818418.chap14-5,properties={foaf_givenname=James M., foaf_name=James M. Hughes, foaf_surname=Hughes, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818418.chap14-aff1]]}]]

/content/10.1128/9781555818418.chap14.fig14-1

Figure 1

Fiscal year 1999 CDC bioterrorism funding. M, millions.

10.1128/9781555818418/fig14-1_thmb.gif

10.1128/9781555818418/fig14-1.gif

Figure 1

Fiscal year 1999 CDC bioterrorism funding. M, millions.

References

/content/book/10.1128/9781555818418.chap14

1. Albert, M. J.,, A. K. Siddique,, M. S. Islam,, A. S. Faruque,, M. Ansaruzzaman,, S. M. Faruque,, and R. B. Sack. 1993. A large outbreak of clinical cholera due to Vibrio cholerae non-OJ in Bangladesh. Lancet 341: 704.

2. Berkelman, R. L.,, R. T. Bryan,, M. T. Osterholm,, J. W. LeDuc,, and J. M. Hughes. 1994. Infectious di sease surveillance: a crumbling foundation. Science 264: 368– 370.

3. Berkelman, R. L.,, R. W. Pinner,, and J. M. Hughes. 1996. Addressing emerging microbial threats in the United States. JAMA 275: 315– 317.

4. Bik, E. M.,, A. E. Bunschoten,, R. D. Gouw,, and F. R. Mooi. 1995. Genesis of the novel epidemic Vibrio cholerae O139 strain : evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J. 14: 209– 216.

5. Centers for Disease Control and Prevention. 1993. Hantavirus infection- southwestern United States: interim recommendation for risk reduction. Morbid. Mortal. Weekly Rep.(No. RR-11) 42: 1– 12.

6. Centers for Disease Control and Prevention. 1994. Addressing emerging infectious disease threats: a prevention strategy for the United States. Public Health Service. U.S. Department of Health and Human Services, Atlanta, Ga.

7. Centers for Disease Control and Prevention. 1996. Foodborne outbreak of diarrheal illness associated with Cryptosporidium parvum. Morbid. Mortal Weekly Rep. 45: 783– 784.

8. Centers for Disease Control and Prevention. 1997. Human monkeypox-Kasai Oriental Zaire, 1996-1997. Morbid. Mortal. Weekly Rep. 46: 304– 307.

8.a. Centers for Disease Control and Prevention. 1999. Bioterrorism alleging use of anthrax, and interim guidelines for management-United States, 1998. Morbid. Mortal. Weekly Rep. 48: 69– 74.

8.b. Centers for Disease Control and Prevention. 1999. Update: outbreak of Nipah virus-Malaysia and Singapore, 1999. Morbid. Mortal. Weekly Rep. 48: 335– 337.

9. Childs, J. E., T, G. Ksiazek, C. F. Spiropoulou, et al. 1994. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J. Infect. Dis. 169: 1271– 1280.

10. Chizhikov, V. E.,, C. F. Spiropoulou,, S. P. Morzunov,, M. C. Monroe,, C. J. Peters,, and S. T. Nichol, 1995. Complete genetic characterization and analysis of isolation of Sin Nombre virus. J. Virol. 69: 8132– 8136.

11. Clancy, T. 1996. Executive Orders. G. P. Putnam's Sons, New York, N.Y.

12. Comstock, L. E.,, J. A. Johnson,, J. M. Michalski,, J. G. Morris, Jr.,, and J. B. Kaper. 1996. Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae 0139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol., Microbiol. 19: 815– 826.

13. Danzig, R.,, and P. B. Berkowsky. 1997. Why should we be concerned about biological warfare? JAMA 278: 431– 432.

14. Duchin, J. S.,, F. T. Koster,, C. J. Peters,, G. L. Simpson,, B. Tempest,, S. R. Zaki,, T. G. Ksiazek,, P. E. Rollin,, S. Nichol,, E. T. Umland. et al. 1994. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N. Engl. J. Med. 330: 949– 955.

15. Eickhoff, T. C. 1996. Airborne disease: including chemical and biological warfare. Am. J. Epidemiol. 144: 839– S46.

16. Ferguson, J. R. 1997. Biological weapons and US law. JAMA 278: 357– 360

17. Franz, D. R.,, P. B. Jahrling,, A. M. Friedlander,, D. J. McClain,, D. L. Hoover,, W. R. Bryne,, J. A. Pavlin,, G. W. Christopher> ,. and E. M. Eitzen, 1997. Clinical recognition and management of patient exposed to biological warfare agents. JAMA 278: 399– 411.

18. Galimand, M.,, A. Guiyoule,, G. Gerbaud,, B. Rasoamanana,, S. Chanteau,, E. Carniel,, and P. Courvalin. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N, Engl. J. Med. 337: 677– 680.

19. Georges-Courbot, M. C.,, C. Y. Lu,, J. Lansoud-Soukate,, E. Leroy,, and S. Baize. 1997. Isolation and partial molecular characterization of a strain of Ebola virus during a recent epidemic of viral hemorrhagic fever in Gabon. Lancet 349: 181.

20. Gore, A. 1996. Emerging infections threaten national and global security. ASM News 62: 448– 449.

21. Henderson, D. A. 1999. The looming threat of bioterrorism. Science 283: 1279– 1282.

22. Hughes, J. M., 1998. Addressing the challenges of emerging infectious diseases: implementation of the strategy of the Centers for Disease Control and Prevention, p. 261– 269. in W. M. Scheld,, D. Armstrong,, and J. M. Hughes (ed.), Emerging Infections J. ASM Press, Washington, D.C.

23. Huq, A.,, R. R. Colwell,, M. A. R. Chowdhury,, B. Xu,, S. M. Moniruzzaman,, M. S. Islam. M. Yunus, and M. J. Albert. 1995. Coexistence of Vibrio cholerae O1 and O139 Bengal in plankton in Bangladesh. Lancet 345: 1249.

24.Institute of Medicine, National Research Council. 1999. Chemical and Biological Terorrism. National Academy Press, Washington, D.C.

25. Kadlec, R. P.,, A. P. Zelicoff,, and A. M. Vrtis. 1997. Biological weapons control: prospects and implication for the future. JAMA 278: 351– 356.

26. Kaufmann, A. F.,, M. I. Meltzer,, and G. P. Schmid. 1997. The economic impact of a bioterrorist attack: are prevention and post attack intervention programs justifiable? Emerg. Infect. Dis. 3: 83– 94.

27. Kolavic, S. A.,, A. Kimura,, S. L. Simons,, L. Slutsker,, S. Barth, .nd C. E. Haley. 1997. An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination. JAMA 278: 396– 398.

28. Ksiazek, T. G.,, C. J. Peters,, P. E. Rollin, et al. 1995. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am. J. Trap. Med. Hyg. 52: 117– 123.

29. Kumar, S. 1995. Surat plague caused by a novel strain. Lancet 345: 1626.

30.. Lalitha, M. K.,, and M. K. Thomas. 1997. Pennicillin resistance in Bacillus anthracis. Lancet 349: 1522.

31. Laughlin, L. W.,, J. M. Meegan,, L. J. Strausbaugh,, D. M. Morens,, and R. H. Watten. 1979. Epidemic Rift Valley fever in Egypt: observation of the spectrum of human illness. Trans. R. Soc. Trap. Med. Hyg. 73: 630– 633.

32. Lederberg, J. 1996. Infectious disease-a threat to global health and security. JAMA 276: 417– 419.

33.Lederberg J. 1997. Infectious disease and biological weapons: prophylaxis and mitigation. JAMA 278: 435– 436.

34. LeDuc, J. W. 1996. World Health Organization strategy for emerging infectious diseases. JAMA 275: 318– 320.

35. LeDuc, J. W. 1996. WHO program on emerging virus diseases. Arch. Virol.(Suppl.) 11: 13– 20.

36. Marrie, T. J.,, D. Langille,, V. Papukna,, and L. Yates. 1989. Truckin' pneumonia— an outbreak of Q fever in a truck repair plant probably due to aerosols from clothing contaminated by contact with newborn kittens. Epidemiol. Infect. 102: 119– 127.

37. McDade, J. E.,, C. C. Shepard,, D. W. Fraser,, T. R. Tsai,, M. A. Redier,, and W. R. Dowdle. 1977. Laboratory investigation team, Legionnaires' disease. 2. Isolation of a bacterium and demonstration ofits role in other respiratory diseases. N. Engl. J. Med. 297: 1197– 1203.

38. Mitcbell, P. 1997. ProMed-mail: outbreak intelligence or rash reporting? Lancet 350: 1610.

39. National Science and Technology Council. 1995. Report of the NTSC Committee on International Science, Engineering, and Technology (CISET) Working Group on Emerging and Re-emerging Infectious Diseases. Executive Office of the President of The United States, Washington, D.C.

40. Nichol, S. T.,, C. F. Spiropoulou,, S. Morzunov,, P. E. Rollin,, T. G. Ksiazek,, H. Feldmann,, A. Sanchez,, J. Childs,, S. Zaki,, and C. J. Peters. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262: 914– 917.

41. Osterholm, M. T.,, G. S. Birkhead,, and R. A. Meriwether. 1996. Impediments to public health surveillance in the 1990s: the lack of resources and the need for priorities. J. Public Health Manage. Pract. 2( 4): 11– 15.

42. Sanchez, A.,, T. G. Ksiazek,, P. E. Rollin,, C. J. Peters,, S. T. Nichol,, A. S. Khan,, and B. W. Mahy. 1995. Reemergence of Ebola virus in Africa. Emerg. Infect. Dis. 1: 96– 97.

43. Schmaljohn, A. L.,, D. Li,, D. L. Negley,, D. S. Bressler,, M. J. Turell,, G. W. Korch,, M. S. Archer,, and C. S. Schmaljohn. 1995. Isolation and initial characterization of a newfound hantavirus from California. Virology 206: 963– 972.

44. Tipple, M.,, R. C. Knudsen,, S. Morse,, J. Foster,, and J. Y. Richmond. 1997. New federal regulations for transfer of infectious agents and toxins. ASM News 63: 66– 67,

45. Torok, T. J.,, R. V. Tauxe,, R. P. Wise,, J. R. Livengood,, R. Sokolow,, S. Mauvais,, K. A. Birkness,, M. R. Skeels,, J. M. Horan,, and L. R. Foster. 1997. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA 278: 389– 395.

46. Tucker, J. B. 1997. National health and medical services response to incidents of chemical and biological terrorism. JAMA 278: 362– 368.

47.. United States Army Medical Research Institute of Infectious Diseases. 1998. Medical Management of Biological Casualties Handbook, 3rd ed. United States Army Medical Research Institute of Infectious Diseases, Frederick, Md.

48. Weber J. T.,, R. G. Hibbs, Jr.,, A. Darwish,, B. Mishu,, A. L. Corwin,, M. Rakha, et al. 1993. A massive outbreak of type E botulism associated with traditional salted fish in Cairo. J. Infect. Dis. 167: 451– 454.

49. Zajtchuk, R.,, and R. F. Bellamy (ed,.). 1997. Textbook of Military Medicine Medical Aspects of Chemical and Biological Warfare. Part I. Warfare, Weaponry, and the Casualty ( F. R. Sidell,, E. T. Takafuji,, and D. R. Franz, specialty ed.). Office of the Surgeon General, United States Army, Washington, D.C.

50.Zaki, S, R. P, W, Greer, L, M, Coffield, C, S, Goldsmith, K. B. Nolte, K. Foucar, R. M. Feddersen, R. E. Zumwalt, G. L Miller, A. S. Khan, et al. 1995. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am. J. Pathol. 146: 552– 579.

Tables

The Role of the Public Health Community in Detecting and Responding to Domestic Terrorism Involving Infectious Agents

/content/10.1128/9781555818418.chap14.tab14-1

Table 1

Bioterrorism threats a

10.1128/9781555818418/tab14-1_thmb.gif

10.1128/9781555818418/tab14-1.gif

Table 1

Bioterrorism threats a

/content/10.1128/9781555818418.chap14.tab14-2

Table 2

Selected illnesses that may result from bioterrorism

10.1128/9781555818418/tab14-2_thmb.gif

10.1128/9781555818418/tab14-2.gif

Table 2

Selected illnesses that may result from bioterrorism

/content/10.1128/9781555818418.chap14.tab14-3

Table 3

Naturally occurring infectious disease outbreaks that could have been mistaken for bioterrorism

10.1128/9781555818418/tab14-3_thmb.gif

10.1128/9781555818418/tab14-3.gif

Table 3

Naturally occurring infectious disease outbreaks that could have been mistaken for bioterrorism

/content/10.1128/9781555818418.chap14.tab14-4

Table 4

CDC's collaborative role in combating bioterrorism

10.1128/9781555818418/tab14-4_thmb.gif

10.1128/9781555818418/tab14-4.gif

Table 4

CDC's collaborative role in combating bioterrorism

/content/10.1128/9781555818418.chap14.tab14-5

Table 5

Goals of Presidential Decision Directive 62

10.1128/9781555818418/tab14-5_thmb.gif

10.1128/9781555818418/tab14-5.gif

Table 5

Goals of Presidential Decision Directive 62